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Abstract-In this paper we extend the Moolgavkar-Venzon-Knudson two-stage model into nonhomo- 
geneous cases. The probability generating functions (PGF) of initiated cells and tumors are derived under 
very general conditions. Using these PGFs we then obtain expected incidence functions of tumor and 
provide an iterative procedure for computing probability distributions of tumors. These results can be 
used to take account of time-varying exposures to help identify etiologic agents and to assess their 
mechanisms of action in epidemiologic studies. 
1. INTRODUCTION 
Multistep theories of carcinogenesis assume that cancer develops from a single normal stem cell 
which has undergone a series of irreversible and heritable changes related to the cell’s release from 
growth control and its ability to invade other tissue Cl]. Furthermore, cell proliferation and 
differentiation are also believed to be important aspects of carcinogenesis [2-53. Animal experiments 
involving different tumor sites (e.g. skin, liver, breast and bladder) have identified and characterized 
two primary stages of the carcinogenic process, initiation and promotion, both of which are 
influenced by cell proliferation. 
The initiation phase is characterized by an irreversible alteration in the genetic expression of a 
cell that produces a heritable change in the cell’s phenotype. Berenblum and Shubik’s [6] early 
skin-painting studies demonstrated that exposure to an initial agent produced changes that persisted 
for many months following termination of exposure. Experiments with radiation and chemically- 
induced mutagenesis have indicated that at least one round of cell proliferation is required before 
the mutational change becomes permanent [7,8]. Because of these characteristics, it is thought 
that initiation involves a mutational event in a cell’s DNA, though this has not been demonstrated 
conclusively. A second mutational change is thought to be necessary before a partially transformed 
ceil can become fully malignant. The actual mechanisms involved in these cellular changes are 
unknown, but it is hypothesized that they involve the activation of oncogenes [9]. The promotion 
phase is less well characterized. Many believe that it involves differential selection of initiated cells 
(e.g. an increased rate of cell division or increased resistance to terminal differentiation) followed 
by clonal expansion of these selected cells. This phase is thought to involve epigenetic changes such 
as modifications in cell-to-cell communication through gap junctions [lo]. 
To provide a mathematical description of the carcinogenic process which can be used to interpret 
the results of experimental animal and human epidemiologic studies, Moolgavkar et al. [ 11,121 
proposed a two-stage model of carcinogenesis. They modeled only two stages because no more 
than two distinct stages have been experimentally demonstrated. This model assumes that a 
malignant tumor develops from a normal stem cell after two cellular changes such as activation of 
cellular oncogenes; it differs from the commonly-used Armitage-Doll multistage model [ 13,141, in 
that the two-stage model includes stochastic birth and death processes to describe cell proliferation 
and differentiation of both normal stem cells and premalignant initiated cells. (i.e. cells which have 
undergone only the first cellular change). By assuming different tissue growth patterns, Moolgavkar 
and Knudson [12] showed their model could fit incidence curves of all human cancers while the 
Armitage-Doll model could only fit most tumors of adult onset. In addition, Moolgavkar [lS] 
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and Tan and Gastardo [16] have shown that the Moolgavkar-Venzon-Knudson (MVK) two- 
stage model provides an explanation for the results of initiation-promotion animal carcinogenesis 
experiments, the initiator affecting the rate of occurrence of the first cellular change and the 
promoter affecting the proliferation rate of the initiated cells. The discovery of antioncogenes [ 173 
provides biological support for the MVK model. As noted by Moolgavkar [lS], pedigree analyses 
have shown that human cancers in some families are transmitted in an autosomal-dominant fashion. 
Cytogenetic analysis of these hereditary cancers have revealed that particular genes are deleted. 
Thus, in contrast, to oncogenes, it is the inactivation of these antioncogenes that leads to malignancy. 
Examples of antioncogenes include the retinoblastoma rb gene on chromosome 13 [19-211 and 
the Wilm’s tumor wm gene on chromosome 1 lp [22-241. 
The MVK model assumes constant time-homogeneous rates of cellular change from normal to 
initiated cells and proliferation and differentiation rates of initiated cells. However, for many human 
cancers these rates are thought to be related to endogeneous and exogeneous carcinogenic exposures 
which may vary over an individual’s life. For example, it is well-known that cell proliferation and 
differentiation rates are related to estrogen levels which vary according to age and environmental 
stimulations [25-271. In addition, exposure to the carcinogens contained in cigarette smoke occurs 
only during a portion of an individual’s lifetime and at varying levels when smokers change to 
filter or low-tar cigarettes. Exposure to carcinogens in the work place also vary with calendar time 
as an individual’s job changes and as the work site is “cleaned up”. In order to take account of 
these time-varying risk factors when studying etiologic agents to assess their mechanism of 
carcinogenic action, it is necessary to develop a nonhomogeneous stochastic model of carcinogenesis. 
The purpose of this paper is to extend the MVK homogeneous model to nonhomogeneous cases. 
In this paper we shall only be concerned with the theoretical development, reserving for a subsequent 
report its application to data from epidemiologic studies of lung cancer and breast cancer. 
2. THE MODEL AND THE PROBABILITY GENERATING FUNCTION 
Let N(t), 1(t) and T(t) be the numbers of normal stem cells, initiated cells (or intermediate cells) 
and tumors at time t, respectively. Let ~(x,,x,,x~; t,, t) = ;(to, t) be the probability generating 
function (PGF) of (N(f), I(r), T(r)), given (N(t,) = N,,I(t,) = T(r,) = 0); I,&~, x,; r,,, r) = <(I, x2, x,; 
r,, r) = t,b(ro,r) the PGF of (I(r),T(r)). given (N(r,) = N,,I(r,) = T(r,) = 0); ~(x,,x,;ro,r) = $(ro,r) 
the PGF of (1(r), T(r)), given (I(r,) = 1, N(r,) = T(r,) = 0) and g(x,;r,,t) = $(l, x3; r,, r) = g(ro,r) 
the PGF of T(t), given (N(r,) = N,,I(r,) = T(r,) = 0). (Note that initiated cells would not mutate 
back to normal stem cells.) To derive these generating functions. we shall make the following 
assumptions (i)-(v). These assumptions have also been made by Moolgavkar and Venzon [ 1 l] and 
Moolgavkar and Knudson [12]. However, our model is more general since we do not assume 
constant mutation rates and constant birth and death rates for normal stem cells and initiated 
cells. 
(i) At time t,,, there are N, normal stem cells. For adult tissues, No is usually very 
large (N, - lo6 - 10’). 
(ii) During [r, r + At], the probability that a normal stem cell at time r yields one 
normal stem cell and one initiated cell at r + At is a,(r)Ar + o(Ar), where 
lim o(Ar)/Ar = 0. Similarly, the probability that an initiated cell at time r yields 
At-0 
one initiated cell and one tumor cell at r + At is a,(r)Ar + o(Ar). It is assumed 
that the q(r)s are nonnegative functions of r. 
(iii) The normal stem cells and initiated cells are assumed to follow nonhomogeneous 
birth-death processes. The birth rate and the death rate for normal stem cells 
and for initiated cells are given, respectively, by (b,(r), d,(r)) and (b2(r), d2(r)). It 
is assumed that the b,(r)s and the di(r)s are nonnegative functions of r. 
(iv) As in Moolgavkar and Knudson [12], we assume that tumor cells grow 
instantaneously into cancer tumors. Since the observed incidences for human 
cancers are normally for a period of 1 or 5 years, this assumption suggest that 
for fitting incidence curves, one may ignore the time elapsed between the birth 
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of tumor cells and the development of a tumor. 
(v) The birth-death processes and the mutation processes are independent of one 
another and each cell goes through the same processes independently of other 
cells. 
Note that if ai = ai, hi(t) = bi and d,(t) = di are independent of t, the above model reduces to 
the model considered by Moolgavkar and Knudson [123. In deriving the mathematical results, we 
note that al(t) is usually very small for all t(al(t) = lo-‘). Thus for adult tissues, one would expect 
0 < Noa, < q, for some constant c0 t/t. This suggests a Poisson distribution for the mutation 
process. 
Theorem 1 
Under assumptions (i)-(v), [(to, t) and &to, t) satisfy, respectively, the following first-order partial 
differential equations (x = x,,y = x2, z = x3): 
+ fy2bAt) + y@ - lb2(t) + d,(t) - yCb2(0 + d2(Ol} gi(fo, t), 
+ 
i(h, loI = xNo; (1) 
and 
$4& 0 = {_v2W) + Y(Z - lb2@) + d,(t) - yCb2W + d2Wl} $$Qo. 0, MO, to) = Y. (2) 
Proof. Using Kolmogorov’s forward equation, the proof is straightforward. 
It is extremely difficult to solve equation (1) but equation (2) can readily be solved under some 
important special cases (see Section 4). To seek an approximate solution to equation (l), we put 
tli(to, t) = exp - 
il 
’ [b,(x) - di(x)] dx , 
10 
i.i(tO, r) = bi(x)~i(to~ X) d-x, 
and 
h(s; to,t) = 1 - (s - l){(s - l)Ai(to, t) - r],(t,,t)}-‘, i = 1,2. 
Then, one has the following theorem for approximating [(to, t). 
Theorem 2 
Suppose that N, is very large and al(t) very small Vt but N,a,(t) is finite Vt. Then, under 
assumptions (i)-(v), we have, to the order O(N, ‘): 
where 
Pl(X,i to, 4 = {@-li(~; to, wu}“=J,(x,;“,,). (3) 
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Proof. An elementary proof of Theorem (2) is given in the Appendix. 
Putting xi = 1 in equation (3), we have the following corollary for the approximation of i&to, t). 
Corollary 
Under the assumptions of Theorem (2), we have, to the order O(N; ‘): 
(4) 
where pi(t,,u) is the expected number of normal stem cells at time u given one normal stem cell 
at t = r,(u 2 to). 
The above corollary suggests a nonhomogeneous filtered Poisson process for (I(r), T(r)). (See 
Parzen [28, p. 1563.) 
Remark 
Theorem (2) suggests that to the order CJ(N; ‘), an approximate solution to equation (1) is given 
by equation (3). 
3. THE EXPECTED INCIDENCE FUNCTION 
Let i(r) be the expected incidence function of a tumor at time r and E{l(t)I 7’(r) = 0) the 
conditional expected number of initiated cells at time r given N(r,) = N, and given no tumors at 
time t. Then 
A(r) = r2(r)E{l(r) 1 T(r) = 0). (5) 
Let ~z(ro.r) be the conditional expected number of initiated cells at time t given one initiated 
cell at time r, and given no tumors at time t. Put &l, 0; t,, r) = 410(r,, t). Taking the derivative of 
Il/(t,,t) in equation (4) with respect to x2 and setting x2 = 1 and x3 = 0, we obtain: 
Now if r,(t) is very small Vt (usually a*(r) zz lo-‘), then $iJu,r) z 1 and pz(u,r) z 
exp(g:[b,(x) - d,(x)] dx}. It follows that, when a,(r) is very small Vr, we have, approximately: 
i.(r) = No&) 
s 
f 
xi(0i(ro9 u)exp [b2(x) - d2(x)] dx du. (7) 
10 
Some special cases 
(a) If ai = zi, b*(r) = b, and d,(r) = d2 are independent of t, then approximation (7) reduces to 
the incidence function given in Moolgavkar and Knudson [12]. 
(b) Assume that the time interval [to, t] is divided into k subintervals lj = [tj- 1, rj), j = 1,. . . , k - 1 
and !k = [tk- ,,tJ, where tk = t, and that in lj, j = 1,. .., k, a,(r) = aij, hi(r) = bij and d,(t) = dij, 
i = 1,2. Then approximation (7) reduces to 
z Nea,, i aij 
’ j 
E.(r) s p,(r,, u)clz(u, t,)du> j=l fj- 1 
where ~JU, t,J = exp(fi[b,(x) - dAx)l dx}. 
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NOW, for tj_1 < u < tj: 
No,4(to, u) z N,exp [b,(x) - 4(x)1 dx 
s ” [b,(x) - d,(x)1 dx + L-b,(x) - d,(x)1 dx ‘j- 1 
j-1 
= N,exp 1 &ldu + EIj(U - tj- 1) 
tJ=1 
= Nj_ 1 exp[sij(u - tj- ,)I, 
where Eij = b, - dij, l, = t, - t,_ 1 and Nj- 1 = No exp 
stem cells at t = tj_ 1 given N(t,) = N,; and 
is the expected number of normal 
4 
~~04 t3 = exp CM4 - U41 dx 
= exp { s’Cbz(x) - &(x)1 dx + i 
” 
1” Cb#) - d&)1 dx} 
u=i+ 1 I,.-, 
= exp EZXtj - U) + f_ Ezotv . 
v=j+ 1 1 
It follows that 
‘j 
NO s P,(to,u)P,(u,tAdu = Nj-1 [“(I, W~2”S”)]j- eXp[E,j(u - tj- 1) + Ezj(tj - u)] du 'j-1 'j- 1 
where mj(z) = exp(szjz) and Nj(x) = Nj_ iexp(sljx) is the expected number of normal stem cells at 
time x(tj_ 1 < x), given N,_i normal stem cells at t = tj-1. 
Putting clj(sj) = EiJ@ Nj(x)mj(<j - x)dx, then 
(9) 
Formula (9) was first given by Tan and Gastardo L-163. 
4. THE PROBABILITY DISTRIBUTION OF THE NUMBER OF TUMORS 
Putting xz = 1 in equation (4), we obtain an approximation to the PGF g(to, t) of the number 
of tumors at, time t, given (N(t,) = No. l(t,) = T(t,) = 0). Let Pj(to, t) be the probability ofj tumors 
at time t, given (N(t,) = No, I(to) = T(t,) = 0). Then 
(j!)pj(tO,t) = {d’g(tO,t)/aX<}~~=O. (10) 
nrr 9:8-E 
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-4dt0, t) + f xj,qj(t,t t) , j=l 1 
where 
s t (- 1)60jqj(to, t) = No a~(u)~l(to, u)Wj(u, t)du 10 
and 
WI@, t) = {a$#& t) - 1]/?X<)X3=0, x2 = 1; 
6,j being Kronecker’s 6. Then, using a procedure given by Tan [29,30-J, P,{tO,r) is computed by 
the following iterative procedure: 
PoOo, t) = evC-qoOo, 01; 
forj > 1, 
Pj(tO, t) = Jo’ ‘~ ( > p~(tO9 r)4j-u(r0, f). u=o (11) 
To compute PAtor t) using equation (1 l), one would need solution &to, t) of equation (2). As we 
shall see, for the following important special cases, solution &ro.t) of equation (2) is readily 
available. 
Some important special cases 
(a) If b,(t) = b,, d,(t) = d, and a;(t) = a2 are independent oft, then the solution of equation (2) 
is 
4(toTt) = W2,x3;t - to,b2,d2,a2) = CY, + y2w(x2,x3;to,t)l Cl + w(x,,.u,;t,,t)]-‘, (12) 
where 
4x2, x3; to9 t) = (x2 - y,kwC- b2(y2 - yJ(t - fO)l/(y2 - x2) 
and y, > y, are the two real roots of 
b,x2 - (b, + d, + a2 - a,x,)x + d2 = 0. 
Note that equation (12) is also the solution of the following Ricatti equation given by Moolgavkar 
and Venzcn [ 111: 
$ WO, r) = b242(k,r d + Ca2x3 - (b2 + d2 + a2)14(to, ~1 + d2, &to, to) = x2. 
(b) If d2(t) = 0 Vt, then solution $(to, t) of equation (2) is 
&tOvc) = x2/{ u(x3; f,, t) - x2v/(x3; t,, f,), (13) 
where 
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U(x,; to, t) = exp 
and 
Mackillop et al. [4], Buick and Pollak [2] and Oberley and Oberley [31] have provided much 
evidence supporting the idea that normal stem cells become immortalized by the loss of differentiation 
capability (see also Matsumura et al. [S] and Marx [32]). These results suggest that the assumption 
d2(t) = 0 Vt may not be very restrictive. 
(c) Assume that the time interval [to, t] is divided into k subintervals lj = [tj_ 1, tj),j = 1,. . . , k - 1, 
I, = [tk _ 1, tJ with t = t,; assume further that in the jth interval, 
bz(t) = bzj,dz(t) = dzj and u,(t) = ~1~~. 
To obtain the solution of equation (2), we define 
and, for c = 1,. . . , k - 1, 
Then, by the chain rule, it is easy to show that gl(to,tk) with t = tk is the solution of equation 
(2). Similarly, for tj- 1 < u < tj, j = 1,. . , k, gj(u, tJ = $,{gj+ l(tj, tk), ~3; tj- 1, U, b,j, d,j, atj> is the 
solution of 
g&u, t) = {X.:Ut) + x2 ( x3 - lb2(t) + d2W - x2Cb2(t) + d2(Ol) $ &u, 0, 
where t = t, and Cp(u, u) = x2. 
On substituting these solutions into formula (4), we obtain 
al(u)~l(to, u)C&u, t) - 11 du 
al(+r(roY u)Cgl(u, rt) - 11 du . (14) 
Note that formula (14) is comparable to formula (2.4) of Tan and Gastardo [16]. With the 
solution of equation (2) available, one may readily obtain wj(u, t) by taking partial derivatives of 
$(u, t) with respect to x3 and setting x2 = 1 and x3 = 0. [For cases (a) and (c), Tan and Gastardo 
[33] have provided an iterative procedure to evaluate wj(u,t).] Thus, f’j(to,r) can readily be 
computed by formula (11). For case (c), Tan and Gastardo [16] have in fact computed these 
probabilities for some simulated data of initiation and promotion experiments. 
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5. SUMMARY 
In the previous section, we derived equation (7) to give an approximation to the age-specific 
cancer incidence as a function of the time-varying rates of cellular mutation, proliferation and 
differentiation. In many epidemiologic studies of cancer risk factors are related to time as measured 
by both age and calendar time. Therefore, it is of major importance that proper account is taken 
of these time factors when analyzing and interpreting these data. The nonhomogeneous two-stage 
model provides a useful tool for the identification of etiologic agents and to assess their mechanisms 
of action. In a follow-up paper we shall apply this model to epidemiologic data to analyze the 
relationships between lung cancer and cigarette smoking and between breast cancer and endogeneous 
estrogens. 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Il. 
REFERENCES 
E. Farber. The multistep nature of cancer development. Cancer Res. 44,4217-4223 (1984). 
R. N. Buick and M. N. Pollak, Perspective on clonogenic tumor cells. stem cells and oncogenes. Cancer Rex 44. 4909- 
4918 (1984). 
A. R. Kennedy and J. B. Little, Evidence indicating that the second step in X-ray induced transformation in ~‘rrro ccurs 
during cellular proliferation. Rndiar. Res. 99. 228-248 (1984). 
W. J.-Mackillop. A. Ciampi and R. N. Buck, A stem cell model of human tumor growth: implications for tumor cell 
clonogenic assays. J. natn. Cancer Inst. 70, 9-16 (1983). 
T. Matsumura. M. Hayashi and R. Konishi, Immortalization in culture of rat cells: a genealogic study. J. narn. Cancer 
Inst. 74, 1223-1232 (1985). 
1. Berenblum and P. Shubik, A new, quantitative approach to the study of the stages of chemical carcinogenesis in the 
mouse’s skin. Er. J. Cancer 1, 383-391 (1947). 
C. Borek and L. Sachs. The number of cell generations required to fix the transformed state. Proc. natn. Acad. Sci. 
L’.S.A. 59, 83-85 (1968). 
T. Kalunaga, Requirement for cell replication in the fixation and expression of the transformed state in mouse cells 
treated with 4-nitroquinoline-l-oxide. Inf. J. Cancer 14, 736-742 (1974). 
H. Land. L. F. Parada and R. A. Weinberg, Cellular oncongenes and multistep carcinogenesis. Science 222. 771-777 
I 1983). 
J. E. Trosko. C. Chang and A. Medcalf, Mechanisms of tumor promotion: potential role of intercellular communication. 
Cancer Inresr. 1, 51 l-526 (1983). 
S. H. Moolgavkar and D. J. Venzon, Two event models for carcinogenesis: Incidence curves for childhood and adult 
cancer. Marhl Biosci. 47, 55-77 (1979). 
12. S. H. Moolgavkar and A. G. Knudson, Mutation and cancer: a model for human carcinogenesis. J. narn. Cancer Insr. 
66, 1037-1052 (1981). 
13. P. Armitage and R. Doll, The distribution of cancer and multistage theory of carcinogenesis. Br. J. Cancer 8, l-12 
(1954). 
14. P. Armitage and R. Doll. Stochastic models for carcinogenesis. In Fourrh Berkeley Symposium on Marhemaricul Statistics 
and Prohahiliry, pp. 19-38. Univ. California Press, Berkeley, Calif. (1961). 
15. S. H. Moolgavkar, Model for human carcinogenesis: action of environmental agents. Enrir. HIrh Persp. 50. 285-291 
(1983). 
16. W. Y. Tan and M. T. C. Gastardo, On the assessment of effects of environmental agents on cancer tumor development 
by a two-stage model of carcinogenesis. Marhl Biosci. 73, 143-155 (1985). 
17. A. G. Knudson. Hereditary cancer, oncogenes and antioncogenes. Cancer Rex 45, 1437-1443 (1985). 
18. S. H. Moolgavkar. Carcinogenesis modeling: from molecular biology to epidemiology. A. Rev. pub/. Hlrh 7, 151-169 
(1986). 
19. W. K. Cavenee er al.. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 305. 719- 
784 (1983). 
20. W. K. Cavenee er al.. Genetic origin of mutations predisposing to retinoblastoma. Science 228, 501-503 (1985). 
21. T. P. Dryja et al., Homozygosity of chromosome 13 in retinoblastama. New EngI. J. Med. 310(9), 550-553 (1984). 
22. A. Koufos et al.. Loss of alleles at loci on human chromosome I1 during genesis of Wilm’s tumour. Nature 309 (IO), 
I 70- I72 (I 984). 
23. E. R. Fearson. B. Volgestein and A. P. Feinberg, Somatic deletion and duplication of genes on chromosome II in 
Wilm’s tumours. Narure 309(l), 174-176 (1984). 
24. S. H. Orkin rr al.. Development of homozygosity for chromosome 1 Ip markers in Wilm’s tumors. Narure 309, 172- 
174 ( 1984). 
25. B. Armstrong. Endocrine factors in human carcinogenesis. IARC Sclenrific Puhl. No. 3Y. In Hosr Fwrors in Humun 
CarcYno~enesis, Lyon, France (1982). 
26. N. E. Day. Epidemiological evidence of promotion effects-the example of breast cancer. In Carcinogenesis (Edited by 
E. Hecker et al.). Raven Press, New York (1982). 
27. M. Pike, Age-related factors in cancers of the breast, endometrium and ovary. In Symp. on Time-related factors in 
Cancer Epidemology, 15-17 April, NCI/NIH, Bethesda, Md (1985). 
28. E. Parzen. Stochastic Processes. Holden-Day, San Francisco, Calif. (1962). 
29. W. Y. Tan, On the distribution of number of mutants in cell populations. SIAM JI appl. Math. 42, 719-730 (1982). 
30. W. Y. Tan. On the distribution of number of mutants at the hypoxanthine-quanine phorsphoribosal transferase locus 
m Chinese hamster ovary cells. Math/ Biosci. 67, 175-192 (1983). 
A nonhomogeneous two-stage model of carcinogenesis 639 
31. L. W. Oberley and T. D. Oberley, The role of superoxide dismutase and gene amplification in carcinogenesis. J. thror. 
Biol. 106, 403-422 (1984). 
32. J. L. Marx, The Yin and Yang of cell growth control. Science 232, 1093-1095 (1986). 
33. W. Y. Tan and M. T. C. Gastardo, On the assessment of effects of environmental agents on cancer tumor development 
by a two-stage model of carcinogenesis. Technical Report 84-7, Dept of Mathematical Sciences. Memphis State Univ.. 
Memphis, Tenn. (1984). 
34. K. B. Athreya and P. E. Ney, Branching Processes. Springer, New York (1972). 
APPENDIX 
Proof of Theorem 2 
For proving Theorem 2, we first give the following two lemmas. 
Lemma A.1 
Let N(n), I(n), T(n) be a three-dimensional discrete time branching process with state space S = ((i.j.k). where i. j. k are 
nonnegative integers} and parameter space T = ‘0, 1.2, .}. Denote the transition probability P”(ijk. rsr) by 
P,(ijk,rst) = P,{N(n + 1) = r, I(n + I) = s. T(n + I) = f \ N(n) = i. I(n) = j, r(n) = k). where i. j. k. r, s, t are nonnegative 
integers. Suppose that the transition probabilities P,(ijk, rsr) satisfy the following conditions: 
(i) P.( 100, rst) 
= 41”(r,s) if@, s, t) = (0.0.0). (1,O.O). (2.0.0) or (1.1.0) 
= 0 otherwise; 
= #‘(s. t) if@, s, t) = (O,O,O), (0, LO), (0,2,0) or (0. 1, 1) 
and 
(ii) P”(O10, rsf) 
= 0 otherwise; 
(iii) P#Ol, rsr) 1 = 1 if(r,s,t)=(O,O,l) = 0 if (r,s,r) f (0.0, 1) 
Put: 
and for j < n. 
Oij(X) = x’q:“(2,0) + q:“(O, 0) + x[ 1 - q:“(2,0) - q:“(O, O)]; 
$jj(Xt,X2rX3) = xl,4,j(xZTx3) = X23 
I(lj(j+ I)(XIIX,?*X3) = Illjo+ 1) (x,*xz) = B,,(Xl) + x,(.x1 - 1)q;‘yl. 1). 
4j(j*l)(xL,x3) = Ozj(xz) + xz(13 - 1)q:2’(1. I); 
Then. the PGFs of N(n), I(n) and T(n), given (N(0) = N,, I(0) = T(0) = 0) and (Z(0) = 1, N(0) = T(0) = 0), are given 
respectively by i&,.x2,x3) = {l/l&r .x2,x,)} ‘0 and &+z,xs), where tioO(xl ,x2,x3) = x, and &,(.x~.x~) = x2. 
For the proof of Lemma A.l, see Athreya and Ney [34,p. 1831. 
Remarks 
(1) In Lemma A.1, note that condition (ii) specifies that I-type individuals produce only I-type and T-type progenies 
while condition (iii) specifies that T-type individuals produce only T-type progenies. 
(2) From the definition of composite functions qQjn(x1,x2,x3) and djn(xl,xa), one has immediately that for n > j and i = 1, 
2. ~ n - j, 
and 
Lemma A.2 
Consider the three-dimensional discrete time branching process and the assumptions as given in Lemma A.1. Assume 
that N, is very large and q’.“(l, 1) very small Vn > 0 but N,qb”(l, I) is finite Vn > 0. Then, to the order O(N; I), the PGF 
i,,.(.v, ,x2, x3) is approximated by 
L(x~.x,.x,)z= {h,,(x,V’~exp 1 + CMx,)l-’ x i j.,-,hjAxl) 
,=1 
x C4jn(xz,xJ - 11 Cdhdxl)ldh~j- L~x~)I 
> 
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where hj,(xl) = xl7 ~,,,+I,(x,) = elj(x,), h,,(x,) = hj(,.,,jh,,.,JXI)} for j < n, and 
for 1 <j<n. 
Cdh,,(x,)ldh,,-,,,(x,)l = {&,c,-,,(h ,,-I ,.(xl)}/dh,,_,,.(x,)} 
= $0,,- I,(l.)~).=h~,.~,“,X*,~ 
1. 
ProoJ It suffices to show that 
~~/o.(XI,XZ.X~) = ‘0,(x1) + J$ $ i.j- Ih,“(Xl)[4jn(X2*.r3) - 11 [dh,,(x,)ldh,,-,,,(s,)] 
01 1 
+ O(N,2). 
By Lemma A.1, we have 
(I/o,(x*,x2.xJ) = ior(x,,x*) = e,,(x,) +$x,(x* - 1) 
0 
= h,,(q) + -$h,,(x,)P$,,(.+.xJ - 11.
0 
Suppose that equation (A.2) holds for n = m(m > 1). Then 
IL 0,m+I)(XI,X*,X3) = ~o,CJI,,“+,I(X1~X2).~n,m+l)(X*~X~).X31 
= hmC+ m,m+l~~xlr~2)l +$,E j.,-,h,,C~,,,+,,(x,.x,)l 
cl- I 
x i4,mc4 m,m+l~LQr%~~~31 - 1; 
x {dh~mCljlm,,+,,(~,.xz)lidh,,-,,nC~,,,+,,(~,.~z)l} + 0Wi2) 
Now from Lemma A.l, 
4Jd n,m+,,(~2.~3).~3] = c#J~,~+~,(x~.x~) by definition; v?,,,+~,(x~.x~) = h,,,+,~~.~,) + &,x,(x2 - I)lN,. so that 
h,mCIL m,m+,,b~.xJl = h,,nCh,,m+,,bJl +‘m.~A+ - 1) 
NO 
x Cdh,,,+,~(x,)/dh,,,,,~(.y,)l + W,*) 
= h o,m+I,h) +~h,.+,,,,+,,(\-,)I~,~+~,,,,,,,,,ll,.x,) - 11 
Cdh ,,,+,,(~,,/dho,,,+,,o3 + 0(N,2); 
and,forO<j<m. 
h,mCG m,m+l~CxI~x2)] =hjmChm(m+~,(x~)I + O(N,‘)=h,,,+,,(X,)+O(N,‘) 
Further, by the chain rule, 
{dhoJll,c,+ 11(x, 9 x,)1/d&- ~mCd’m,m+ 1,(X* 2‘AI) 
= {dM+,,m+ I)( ~1, xdldh,, - 1 ,n[hm,n + I ,(x1 )I; 
x {dh,j-,,,CIL,,,+,,(x,,x,)lld’,j-,,~[’~,~+~,(x,)I~-’ 
= {dhonChm(rn+~,(X~)lldh~j-~,~[‘~~~+~~~~)I~ + O(Ni’) 
= [dh,,,+,,(x,)/dh,j-,,,,+,,(x,)I + O(Ni’). 
On substituting these results into tiO,,,,+ ,,(xI.xI.x3) = $OmCti,,,+ I)(XL.XZ)~ kn+ I,(xz~~~).x& we obtain 
IL 
1 Gil+, 
0,m+l,b1,~27~j) = &,+lXxJ + - E ~,-,hj~m+,JxJ 
N,j=l 
x [6j<m+l,(x,tX,)- ‘ltd’~,~+,,(~,)ld’,,~~,,~+~,(~*)I 
+ O(N,q. 
64.2) 
Proof 01 Theorem 2 
Partition the time interval [r,,t] into n = (t - t,)/At units with time unit At (choose At so that n is an integer). Then, 
with the nth time unit corresponding to the nth generation, (N(n), I(n), T(n)) is precisely the discrete time branching process 
model, as given in Lemmas A.1 and A.2, with 
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and 
q:,‘(O,O) = d,(nAt)At + &AC), 
492,O) = b,(nAt)At + o(Ar), 
q;“(l, 1) = a,(nAt)At + o(At), 
q:,‘(l,O) = 1 - [b,(nAtj + d,(nA.t) + z,(nAt)]At + o(At); 
q:*‘(O, 0) = d*(nAt)Ar + o(At), 
4;*‘(2,0) = b*(nAr)At + o(At), 
qL2’(1, 1) = a*(nAr)At + o(At), 
qi*‘(l, 0) = 1 - [b*(nAt) + d*(nAt) + a*(nAr)]Ar + o(Ar) 
It follows that the results of the theorem are derived from those of the discrete time model in Lemma A.2 by letting At + 
0. That is, [(x,, x2, x3; t,, t) = [(r,, t) = Iii0 ~om(x1,x2,x3). Now, with t = nAt, we have 
h n,n+l,(x,) =x1 + [x,(x1 - l)b,W + (1 - x,)d,(t)lAt + o(W. 
and 
4 “(“+ ,,(x*,x~) = x* + [x*(x* - l)b,(nAt)At + (1 - x*)d*(nAt)Ar + x*(x, - l)a*(nAr)Ar] + I. 
Let ,l;l-,,h,,(x,) =j,(x,;y,l) and li_mO&j.(x*,x,) = tix*.x,;y,f), where J = jAt and r = nAr. 
Then, for small Af: 
f,(x,;y,t + At) Z bjc,+,,(x,) 
= b,Jb,,,. ,, (x,)} = b,,{x,(x, - l)b,(nAt) + (1 - x,)d,WW~ + o(W) 
= hjn(x,) + [XI(X, - l)b,bW + (1 - ~,)d,WNlA&h,.(x,) 
1 
T 
so that 
+ o(At) z_f,(x,;y,O + [x,(x, - l)b,(r) + (1 - x,)d,(r)lAr~f,(x,;p,r) + o(W 
1 
_I . 
;f,(x,;YJ) = c x I( x, - l)b,O) + (1 - x,)d,(r)l~/r(x,;y,r). 
I 
with f,(x,;y,y) = x,; and 
&x*.x,:y,’ + At) 2 d’,tn+,Jx*rxa) = 9j.{9.,.+,I(x*,x)),x~I 
= djn(x* + [x*(X* - l)b*(t) + (1 - .x,)d,(r) + X,(X, - l)a*(r)]At + o(Ar),~,) 
= @,dx*.xJ + [x*(x* - l)b*(t) + (1 - x*M*(t) + x*(x3 - 1)a*(t)]At~~,(x*,x3) + o(At) 
2 
2 d(x*,x$y,t) + [x*(x* - l)b*(r) + (1 - x*)d*(t) + x*(x, - l)a*(f)]Af&&x*,x$y.t) + o(At) 
2 
(A.3) 
so that 
~#J(x,,.Y,;Y. t) = [x2(.x2 - l)bAr) + (1 - x2W2(t) + x,(x, - l)a2(t)l~~(x2,.~~;~,f). 
2 
64.4) 
with 4(x2, x,; y, y) = x2. 
Further, Lj = N,q:” (1. 1) z N,z,(y)Ar with y = jAr. and 
goes to 
P,(x,;~,,Y) = C~~,l(';lo,~)IS'I,=/,,,,:~.,, as At-O. 
Note that equation (A.4) is equation (1) of Theorem 1 and the solution of equation (A.3) is 
~~Ob,,(x,)=/,(x,;yrt)= 1 -b, - IKb, - l)R,(~‘,t)--,(y.r)l-‘, 
645) 
as given in Theorem 2. On substituting iir~~ h,,(x,) = f,(_u,; J. I), L^m, @,.(x2, x3) = #(x2, x,; y, t) = &y, r) and equation (AS) 
into equation (A.]) and noting that df~~ $ -+ r0 as AI -0. we have 
I-, 
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x exp 
i 
1 + [/,(x,;to.~)I-‘No 
J 
a(y)~,(xl;to.y)/l(xl;):l) 
‘0 
x [Q(y, 1) - 11 dy + 0th’; ‘). 
